We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$3.13B
AUM Growth
-$203M
Cap. Flow
-$301M
Cap. Flow %
-9.61%
Top 10 Hldgs %
62.45%
Holding
80
New
1
Increased
15
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
BP icon
BP
BP
+$54M
2
EG icon
Everest Group
EG
+$42.4M
3
WTW icon
Willis Towers Watson
WTW
+$41.5M
4
MDT icon
Medtronic
MDT
+$33.9M
5
BKNG icon
Booking.com
BKNG
+$33.7M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$103M
2
BABA icon
Alibaba
BABA
+$96.8M
3
CB icon
Chubb
CB
+$85.4M
4
AON icon
Aon
AON
+$52.7M
5
TME icon
Tencent Music
TME
+$44.9M

Sector Composition

Rank Sector Weight
1 Financials 37.9%
2 Technology 13.3%
3 Communication Services 12.55%
4 Healthcare 11.04%
5 Consumer Discretionary 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORF
51
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.25M 0.1%
68,485
LNTH icon
52
Lantheus
LNTH
$6.67B
$3.18M 0.1%
110,000
ICPT
53
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.75M 0.09%
168,800
JAZZ icon
54
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.67M 0.09%
21,000
PRQR icon
55
ProQR Therapeutics
PRQR
$243M
$2.57M 0.08%
321,360
BKD icon
56
Brookdale Senior Living
BKD
$3.47B
$2.28M 0.07%
442,452
NVST icon
57
Envista
NVST
$4.48B
$2.25M 0.07%
50,000
AERI
58
DELISTED
Aerie Pharmaceuticals
AERI
$1.9M 0.06%
270,000
AXGN icon
59
Axogen
AXGN
$2.44B
$1.69M 0.05%
180,000
+50,000
+38% +$600K
KZR
60
DELISTED
Kezar Life Sciences
KZR
$1.67M 0.05%
10,000
SGMO
61
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.62M 0.05%
216,500
FATE icon
62
Fate Therapeutics
FATE
$296M
$1.58M 0.05%
27,000
ATRA icon
63
Atara Biotherapeutics
ATRA
$77.5M
$1.58M 0.05%
4,000
KURA icon
64
Kura Oncology
KURA
$811M
$1.54M 0.05%
110,000
MGNX icon
65
MacroGenics
MGNX
$240M
$1.12M 0.04%
70,000
INFY icon
66
Infosys
INFY
$49.7B
$968K 0.03%
38,230
-37
-0.1% -$860
PAC icon
67
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$968K 0.03%
7,038
-7
-0.1% -$896
TS icon
68
Tenaris
TS
$28.7B
$911K 0.03%
43,691
-43
-0.1% -$940
AGTC
69
DELISTED
Applied Genetic Technologies Corporation
AGTC
$716K 0.02%
376,900
DCTH icon
70
Delcath Systems
DCTH
$445M
$698K 0.02%
90,000
+10,000
+13% +$94.5K
TLK icon
71
Telkom Indonesia
TLK
$15B
$675K 0.02%
23,272
-22
-0.1% -$597
CABA icon
72
Cabaletta Bio
CABA
$442M
$531K 0.02%
140,000
+20,000
+17% +$213K
CTMX icon
73
CytomX Therapeutics
CTMX
$681M
$520K 0.02%
120,000
VALE icon
74
Vale
VALE
$62B
$487K 0.02%
34,716
-34
-0.1% -$452
BABA icon
75
Alibaba
BABA
$308B
-653,748
Closed -$96.8M

Similar funds

Altrinsic Global Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Altrinsic Global Advisors held 80 positions worth $3.13B, down 6.1% from $3.34B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Altrinsic Global Advisors withdrew a net $301M in Q4 2021, closing 6 positions and reducing 36 holdings. Its most notable exit was Baidu, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 35% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Altrinsic Global Advisors opened a new position in GoDaddy worth $10.9M.

  • Altrinsic Global Advisors's largest Q4 2021 buy was GoDaddy: 127,991 shares worth $10.9M.
  • Altrinsic Global Advisors added most to BP in Q4 2021, an estimated $54M increase.
  • Altrinsic Global Advisors's biggest Q4 2021 reduction was Chubb, cutting an estimated $85.4M.
  • Altrinsic Global Advisors fully exited Baidu in Q4 2021, selling an estimated $103M.
  • Altrinsic Global Advisors's ten largest holdings make up 62% of its $3.13B portfolio in Q4 2021.
  • Altrinsic Global Advisors opened 1 new position and closed 6 in Q4 2021.
  • Altrinsic Global Advisors's portfolio value fell 6.1% quarter-over-quarter to $3.13B.

Based on Altrinsic Global Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.